Hims & Hers Health (XSWX:HIMS) Current Accrued Expense: CHF145 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
78 GF Score
Price CHF22.95
GF Value CHF35.29
! 4 Warning Signs
View Full Analysis

What is Hims & Hers Health Current Accrued Expense?

Hims & Hers Health XSWX:HIMS -2.59% 78 Current Accrued Expense is CHF145 Mil as of Jun. 2026. GuruFocus rates XSWX:HIMS with a GF Score™ of 78/100 and a GF Value™ of CHF35.29. The stock has 4 warning signs investors should review.

Hims & Hers Health's Current Accrued Expense for the quarter that ended in Jun. 2026 was CHF145 Mil.

Hims & Hers Health's quarterly Current Accrued Expense increased from Dec. 2025 (CHF55 Mil) to Mar. 2026 (CHF60 Mil) and increased from Mar. 2026 (CHF60 Mil) to Jun. 2026 (CHF145 Mil).

Hims & Hers Health's annual Current Accrued Expense increased from Dec. 2023 (CHF25 Mil) to Dec. 2024 (CHF45 Mil) and increased from Dec. 2024 (CHF45 Mil) to Dec. 2025 (CHF55 Mil).

Hims & Hers Health Current Accrued Expense Related Terms

Hims & Hers Health Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Current Accrued Expense Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial 10.35 10.70 25.06 45.35 54.89

Hims & Hers Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.38 57.19 54.89 60.36 145.43
XSWX:HIMS
78GF Score
Hims & Hers Health Inc XSWX:HIMS
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of CHF145 Mil mean?
Hims & Hers Health (XSWX:HIMS) has a Current Accrued Expense of CHF145 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Current Accrued Expense too high?
Hims & Hers Health's current Current Accrued Expense is CHF145 Mil. Overall, Hims & Hers Health has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Current Accrued Expense compare to LNTH and AMRX?
Hims & Hers Health's Current Accrued Expense of CHF145 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Current Accrued Expense is CHF145 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current Current Accrued Expense of CHF145 Mil. The stock's GF Value™ is CHF35.29, compared to a current price of CHF22.95 — trading 35% below its estimated fair value. The current Current Accrued Expense is CHF145 Mil. Hims & Hers Health's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current Current Accrued Expense is CHF145 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF22.95 is trading 35% below its estimated GF Value™ of CHF35.29.

Key valuation signals for XSWX:HIMS:

  • Current Accrued Expense: CHF145 Mil
  • GF Value™: CHF35.29 vs. price of CHF22.95 (35% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
78GF Score

Get the complete analysis for XSWX:HIMS

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF22.95
Price
CHF35.29
GF Value